Yuxi Tian1, Martijn J Schuemie2, Marc A Suchard1,3,4. 1. Department of Biomathematics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, USA. 2. Epidemiology Department, Janssen Research and Development LLC, Titusville, NJ, USA. 3. Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles, CA, USA. 4. Department of Human Genetics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, USA.
Abstract
Background: Propensity score adjustment is a popular approach for confounding control in observational studies. Reliable frameworks are needed to determine relative propensity score performance in large-scale studies, and to establish optimal propensity score model selection methods. Methods: We detail a propensity score evaluation framework that includes synthetic and real-world data experiments. Our synthetic experimental design extends the 'plasmode' framework and simulates survival data under known effect sizes, and our real-world experiments use a set of negative control outcomes with presumed null effect sizes. In reproductions of two published cohort studies, we compare two propensity score estimation methods that contrast in their model selection approach: L1-regularized regression that conducts a penalized likelihood regression, and the 'high-dimensional propensity score' (hdPS) that employs a univariate covariate screen. We evaluate methods on a range of outcome-dependent and outcome-independent metrics. Results: L1-regularization propensity score methods achieve superior model fit, covariate balance and negative control bias reduction compared with the hdPS. Simulation results are mixed and fluctuate with simulation parameters, revealing a limitation of simulation under the proportional hazards framework. Including regularization with the hdPS reduces commonly reported non-convergence issues but has little effect on propensity score performance. Conclusions: L1-regularization incorporates all covariates simultaneously into the propensity score model and offers propensity score performance superior to the hdPS marginal screen.
Background: Propensity score adjustment is a popular approach for confounding control in observational studies. Reliable frameworks are needed to determine relative propensity score performance in large-scale studies, and to establish optimal propensity score model selection methods. Methods: We detail a propensity score evaluation framework that includes synthetic and real-world data experiments. Our synthetic experimental design extends the 'plasmode' framework and simulates survival data under known effect sizes, and our real-world experiments use a set of negative control outcomes with presumed null effect sizes. In reproductions of two published cohort studies, we compare two propensity score estimation methods that contrast in their model selection approach: L1-regularized regression that conducts a penalized likelihood regression, and the 'high-dimensional propensity score' (hdPS) that employs a univariate covariate screen. We evaluate methods on a range of outcome-dependent and outcome-independent metrics. Results: L1-regularization propensity score methods achieve superior model fit, covariate balance and negative control bias reduction compared with the hdPS. Simulation results are mixed and fluctuate with simulation parameters, revealing a limitation of simulation under the proportional hazards framework. Including regularization with the hdPS reduces commonly reported non-convergence issues but has little effect on propensity score performance. Conclusions: L1-regularization incorporates all covariates simultaneously into the propensity score model and offers propensity score performance superior to the hdPS marginal screen.
Authors: Sebastian Schneeweiss; Wesley Eddings; Robert J Glynn; Elisabetta Patorno; Jeremy Rassen; Jessica M Franklin Journal: Epidemiology Date: 2017-03 Impact factor: 4.822
Authors: Jessica M Franklin; Wesley Eddings; Peter C Austin; Elizabeth A Stuart; Sebastian Schneeweiss Journal: Stat Med Date: 2017-02-16 Impact factor: 2.373
Authors: Daniel Westreich; Stephen R Cole; Michele Jonsson Funk; M Alan Brookhart; Til Stürmer Journal: Pharmacoepidemiol Drug Saf Date: 2010-12-09 Impact factor: 2.890
Authors: Meijia Zhou; Shirley V Wang; Charles E Leonard; Joshua J Gagne; Candace Fuller; Christian Hampp; Patrick Archdeacon; Sengwee Toh; Aarthi Iyer; Tiffany Siu Woodworth; Elizabeth Cavagnaro; Catherine A Panozzo; Sophia Axtman; Ryan M Carnahan; Elizabeth A Chrischilles; Sean Hennessy Journal: Epidemiology Date: 2017-11 Impact factor: 4.822
Authors: Martijn J Schuemie; M Soledad Cepeda; Marc A Suchard; Jianxiao Yang; Yuxi Tian; Alejandro Schuler; Patrick B Ryan; David Madigan; George Hripcsak Journal: Harv Data Sci Rev Date: 2020-01-31
Authors: Ravindra Ganesh; Colin F Pawlowski; John C O'Horo; Lori L Arndt; Richard F Arndt; Sarah J Bell; Dennis M Bierle; Molly Destro Borgen; Sara N Hanson; Alexander Heyliger; Jennifer J Larsen; Patrick J Lenehan; Robert Orenstein; Arjun Puranik; Leigh L Speicher; Sidna M Tulledge-Scheitel; A J Venkatakrishnan; Caroline G Wilker; Andrew D Badley; Raymund R Razonable Journal: J Clin Invest Date: 2021-10-01 Impact factor: 14.808
Authors: Seng Chan You; Yeunsook Rho; Behnood Bikdeli; Jiwoo Kim; Anastasios Siapos; James Weaver; Ajit Londhe; Jaehyeong Cho; Jimyung Park; Martijn Schuemie; Marc A Suchard; David Madigan; George Hripcsak; Aakriti Gupta; Christian G Reich; Patrick B Ryan; Rae Woong Park; Harlan M Krumholz Journal: JAMA Date: 2020-10-27 Impact factor: 56.272
Authors: Marc A Suchard; Martijn J Schuemie; Harlan M Krumholz; Seng Chan You; RuiJun Chen; Nicole Pratt; Christian G Reich; Jon Duke; David Madigan; George Hripcsak; Patrick B Ryan Journal: Lancet Date: 2019-10-24 Impact factor: 79.321
Authors: Seng Chan You; Harlan M Krumholz; Marc A Suchard; Martijn J Schuemie; George Hripcsak; RuiJun Chen; Steven Shea; Jon Duke; Nicole Pratt; Christian G Reich; David Madigan; Patrick B Ryan; Rae Woong Park; Sungha Park Journal: Hypertension Date: 2021-03-29 Impact factor: 10.190
Authors: Gyu Lee Kim; Yu Hyeon Yi; Hye Rim Hwang; Jinmi Kim; Youngmin Park; Yun Jin Kim; Jeong Gyu Lee; Young Jin Tak; Seung Hun Lee; Sang Yeoup Lee; Youn Hye Cho; Eun Ju Park; Youngin Lee Journal: J Clin Med Date: 2021-05-10 Impact factor: 4.241